| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Revenue | $5.77B | +28.6% |
| Cost of Revenue | $1.58B | +19.9% |
| Gross Profit | $4.19B | +32.3% |
| R&D Expense | $893.9M | +31.3% |
| SG&A Expense | $577.0M | +37.5% |
| Operating Income | $887.1M | +71.8% |
| Pre-tax Income | $729.3M | +229.5% |
| Income Tax | $264.0M | +273.1% |
| Net Income | $465.1M |
| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.28B | +4.0% |
| Accounts Receivable | $626.2M | -8.3% |
| Current Assets | $2.28B | +0.1% |
| Total Assets | $14.21B | -16.9% |
| Current Liabilities | $2.80B | -13.0% |
| Long-term Debt | $6.39B | -28.0% |
| Stockholders' Equity | $4.20B | +4.4% |
| Line Item | 2024-06-30 | Y/Y |
|---|---|---|
| Operating Cash Flow | $967.7M | +24.2% |
| Investing Cash Flow | $2.06B | +136.4% |
| Financing Cash Flow | -$2.96B | -167.3% |
| +209.3% |
| EPS (Basic) | $1.71 | +205.4% |
| EPS (Diluted) | $1.71 | +205.4% |